Non-small cell lung cancer (NSCLC), colorectal cancer (CRC) , gastrointestinal stromal tumor (GIST)
Conditions
Interventions
Gold Standard:Comparison methods :
1. comparison of similar kits
2. Sequencing method.
gene 
analysis 
Manufacturer: 
Flancite 
LTD.
Model: 
Sponsors
Shanghai Chest Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) or gastrointestinal stromal tumor (GIST) were selected as the selected cases in this clinical trial; 2. Some benign tumors were selected as interference samples for detection; 3. The patient's gender and age are not limited; 4. Case group inclusion criteria (meeting (1) (4) or (2) (4) or (3) (4)): (1) Patients with non-small cell lung cancer (NSCLC) were diagnosed by pathology; (2) Patients with colorectal cancer (CRC) were diagnosed by pathology; (3) Patients with gastrointestinal stromal tumor (GIST) were diagnosed by pathology; (4) The percentage of tumor cells was not less than 20%. 5. Inclusion criteria of control group (in accordance with (5)): (5) The pathological diagnosis was benign tumor or inflammatory tissue.
Exclusion criteria
Exclusion criteria: 1. Patients whose samples were stored for more than 24 months after collection; 2. Patients whose tissue samples can not meet the test requirements (e.g. insufficient wax sample, lost wax block, etc.); 3. Repeat sampling in the same case; 4. The number of excess cases (competing for admission); 5. Incomplete and nonstandard sample information, such as lack of traceability key information, unclear diagnosis information, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung and gastrointestinal tumor genes;Positive coincidence rate, negative coincidence rate and total coincidence rate;consistency; | — |
Countries
China
Contacts
Public ContactTang Yuan
West China Hospital of Sichuan University
Outcome results
None listed